Front Row Advisors’s Veradigm MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
MCM
Front Row Advisors's MDRX Position: Q3 2024 in Review
Front Row Advisors sold out of Veradigm (MDRX) in Q3 2024, closing a stake of 220 shares — an estimated $2.09K sold.
Front Row Advisors first reported a position in MDRX in Q4 2017 and held it in 26 quarters. The position peaked at $5K in Q1 2022. 8 funds tracked by Wall St. Rank hold MDRX as of Q3 2024.
- Front Row Advisors reported no remaining Veradigm position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 220 Veradigm shares in Q3 2024, an estimated $2.09K.
- Front Row Advisors first reported a position in Veradigm in Q4 2017 and held it in 26 quarters.
- Front Row Advisors's Veradigm position peaked at $5K in Q1 2022.
- 8 funds tracked by Wall St. Rank held Veradigm as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.